CRISPR gene-editing technique set to push new boundaries

Biotechnology companies are seeking to cure forms of blindness, muscular dystrophy and leukemia.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.